Equity

Board of Directors Home > Equity > Corporate Information > Board of Directors

Syngene International LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539268 NSE Symbol: SYNGENE P/E (TTM) :58.29
ISIN Demat:INE398R01022 Div & Yield %:1.81 EPS (TTM) :11.82
Book Value (RS) :104.1404189 Market Cap (Rs Cr.):27732.79 Face Value (RS) :10
    Change Company 
ChairpersonKiran Mazumdar Shaw
DirectorCatherine Patricia Rosenberg
Independent DirectorPaul Frederick Blackburn
Vijay Kuchroo
Managing Director & CEOJonathan Hunt
Lead Independent DirectorVinita Bali
Company Sec. & Compli. OfficerPriyadarshnini Mahapatra
Independent DirectorSharmila Karve
DirectorCarl Decicco
Independent DirectorKush Parmar

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)